Tentarix Bio unveils $50M for biologics with multiple functions, multiple targets

Healthcare

Biotech startup Tentarix Biotherapeutics has come out of stealth with $50 million and technology that develops biologic drugs endowed with multiple functions. The company aims to develop new multispecific biologic drugs for cancer and autoimmune diseases.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.